AVEO Pharmaceuticals (AVEO) Posts Narrower than Expected Q3 Loss of 69c; Has Capital Through FY13
Tweet Send to a Friend
AVEO Pharmaceuticals (NASDAQ: AVEO) reported Q3 EPS of ($0.69), $0.18 better than the analyst estimate of ($0.87). Revenue for ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
